A Phase I, Single-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics in Intravenous AZD5099 After Single Ascending Doses in Healthy Male and Female Subjects.

Trial Profile

A Phase I, Single-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics in Intravenous AZD5099 After Single Ascending Doses in Healthy Male and Female Subjects.

Suspended
Phase of Trial: Phase I

Latest Information Update: 30 Nov 2011

At a glance

  • Drugs AZD 5099 (Primary)
  • Indications Bacterial infections
  • Focus Adverse reactions
  • Most Recent Events

    • 30 Nov 2011 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
    • 16 Jun 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 26 Apr 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top